NHS Branded Medicines Tranche Framework for London and South of England

Published facts

What the notice says

Buyer

NHS England

Published status

complete

Latest release reference

5804a973-6494-40b3-8ef1-7809f1927694-778994

CPV codes

Common Procurement Vocabulary (CPV) codes: 33600000

Published tags

award

Latest record Bidwake loaded from this source

27 Aug 2026

NHS Branded Medicines Tranche Framework for London and South of England - 1 September 2024 Offer reference number: CM/PHR/22/5689 CM/PHR/22/5689/01 - NHS Framework for Branded Medicines - London & South of England Tranche A. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5689/02 - NHS Framework for Branded Medicines - London & South of England Tranche B. Period of framework: 1 September 2024 to 31 August 2026 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months. CM/PHR/22/5689/03 - NHS Framework for the supply of Omalizumab and Diroximel Fumarate for the Midlands & East and North of England. Period of framework: 1 September 2024 to 31 August 2025 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 24 months.

Open the official Contracts Finder notice

Observed notice trail

How the published record developed

Events follow the publisher date where one is available. “Seen by Bidwake” is the date this service first found the record.

1. Award notice observed

   20 Aug 2024

   Latest variant observed by Bidwake on 16 Jul 2026.

   Open this official Contracts Finder notice

   Record references

   Release reference

   5804a973-6494-40b3-8ef1-7809f1927694-778994

   Published tags

   award

Awards and suppliers

Published award and contract facts

• NHS Branded Medicines Tranche Framework for London and South of England

  Buyer: NHS EnglandSupplier: Accord-UK Ltd

  End date in notice

  31 Aug 2026

  Value shown in notice

  £380,950,720Whole award value; not assigned to one supplier

  Official source

  Open the official Contracts Finder notice for NHS Branded Medicines Tranche Framework for London and South of England

  About this figure

  • This award names more than one supplier but does not divide the published value between them. The figure is shown for context and is not assigned to one supplier.

  View record references

  Source

  Contracts Finder

  Award or lot reference

  ocds-b5fd17-093f7927-fa77-4248-beb7-0c8a9707d58c-1

• NHS Branded Medicines Tranche Framework for London and South of England

  Buyer: NHS EnglandSupplier: AstraZeneca

Related evidence

Published terms and linked processes

No recurrence, renewal or options wording appears in these notices.

No exact source-published process relationship was found.